These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1248 related items for PubMed ID: 8585712

  • 21. Relative contributions of the Candida albicans ABC transporters Cdr1p and Cdr2p to clinical azole resistance.
    Tsao S, Rahkhoodaee F, Raymond M.
    Antimicrob Agents Chemother; 2009 Apr; 53(4):1344-52. PubMed ID: 19223631
    [Abstract] [Full Text] [Related]

  • 22. Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance.
    Sanguinetti M, Posteraro B, Fiori B, Ranno S, Torelli R, Fadda G.
    Antimicrob Agents Chemother; 2005 Feb; 49(2):668-79. PubMed ID: 15673750
    [Abstract] [Full Text] [Related]

  • 23. Molecular mechanisms of fluconazole resistance in Candida dubliniensis isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis.
    Perea S, López-Ribot JL, Wickes BL, Kirkpatrick WR, Dib OP, Bachmann SP, Keller SM, Martinez M, Patterson TF.
    Antimicrob Agents Chemother; 2002 Jun; 46(6):1695-703. PubMed ID: 12019078
    [Abstract] [Full Text] [Related]

  • 24. [Investigation of the expression levels of efflux pumps in fluconazole-resistant Candida albicans isolates].
    Gulat S, Doluca Dereli M.
    Mikrobiyol Bul; 2014 Apr; 48(2):325-34. PubMed ID: 24819270
    [Abstract] [Full Text] [Related]

  • 25. Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus.
    White TC.
    Antimicrob Agents Chemother; 1997 Jul; 41(7):1482-7. PubMed ID: 9210670
    [Abstract] [Full Text] [Related]

  • 26. Azole resistance in a Candida albicans mutant lacking the ABC transporter CDR6/ROA1 depends on TOR signaling.
    Khandelwal NK, Chauhan N, Sarkar P, Esquivel BD, Coccetti P, Singh A, Coste AT, Gupta M, Sanglard D, White TC, Chauvel M, d'Enfert C, Chattopadhyay A, Gaur NA, Mondal AK, Prasad R.
    J Biol Chem; 2018 Jan 12; 293(2):412-432. PubMed ID: 29158264
    [Abstract] [Full Text] [Related]

  • 27. Multiple amino acid substitutions in lanosterol 14alpha-demethylase contribute to azole resistance in Candida albicans.
    Favre B, Didmon M, Ryder NS.
    Microbiology (Reading); 1999 Oct 12; 145 ( Pt 10)():2715-25. PubMed ID: 10537193
    [Abstract] [Full Text] [Related]

  • 28. Functional expression of Candida albicans drug efflux pump Cdr1p in a Saccharomyces cerevisiae strain deficient in membrane transporters.
    Nakamura K, Niimi M, Niimi K, Holmes AR, Yates JE, Decottignies A, Monk BC, Goffeau A, Cannon RD.
    Antimicrob Agents Chemother; 2001 Dec 12; 45(12):3366-74. PubMed ID: 11709310
    [Abstract] [Full Text] [Related]

  • 29. [Investigation of mutations in transcription factors of efflux pump genes in fluconazole-resistant Candida albicans strains overexpressing the efflux pumps].
    Kalkandelen KT, Doluca Dereli M.
    Mikrobiyol Bul; 2015 Oct 12; 49(4):609-18. PubMed ID: 26649419
    [Abstract] [Full Text] [Related]

  • 30. Divergent functions of three Candida albicans zinc-cluster transcription factors (CTA4, ASG1 and CTF1) complementing pleiotropic drug resistance in Saccharomyces cerevisiae.
    Coste AT, Ramsdale M, Ischer F, Sanglard D.
    Microbiology (Reading); 2008 May 12; 154(Pt 5):1491-1501. PubMed ID: 18451058
    [Abstract] [Full Text] [Related]

  • 31. The evaluation of the overexpression of the ERG-11, MDR-1, CDR-1, and CDR-2 genes in fluconazole-resistant Candida albicans isolated from Ahvazian cancer patients with oral candidiasis.
    Maheronnaghsh M, Teimoori A, Dehghan P, Fatahinia M.
    J Clin Lab Anal; 2022 Feb 12; 36(2):e24208. PubMed ID: 34997991
    [Abstract] [Full Text] [Related]

  • 32. The anti-staphylococcal fusidic acid as an efflux pump inhibitor combined with fluconazole against vaginal candidiasis in mouse model.
    Gomaa SE, Abbas HA, Mohamed FA, Ali MAM, Ibrahim TM, Abdel Halim AS, Alghamdi MA, Mansour B, Chaudhary AA, Elkelish A, Boufahja F, Hegazy WAH, Yehia FAA.
    BMC Microbiol; 2024 Feb 10; 24(1):54. PubMed ID: 38341568
    [Abstract] [Full Text] [Related]

  • 33. Resistance mechanisms in clinical isolates of Candida albicans.
    White TC, Holleman S, Dy F, Mirels LF, Stevens DA.
    Antimicrob Agents Chemother; 2002 Jun 10; 46(6):1704-13. PubMed ID: 12019079
    [Abstract] [Full Text] [Related]

  • 34. Transcriptional analyses of antifungal drug resistance in Candida albicans.
    Lyons CN, White TC.
    Antimicrob Agents Chemother; 2000 Sep 10; 44(9):2296-303. PubMed ID: 10952571
    [Abstract] [Full Text] [Related]

  • 35. The quorum-sensing molecule farnesol is a modulator of drug efflux mediated by ABC multidrug transporters and synergizes with drugs in Candida albicans.
    Sharma M, Prasad R.
    Antimicrob Agents Chemother; 2011 Oct 10; 55(10):4834-43. PubMed ID: 21768514
    [Abstract] [Full Text] [Related]

  • 36. Clinically significant azole cross-resistance in Candida isolates from HIV-positive patients with oral candidosis.
    Cartledge JD, Midgley J, Gazzard BG.
    AIDS; 1997 Dec 10; 11(15):1839-44. PubMed ID: 9412702
    [Abstract] [Full Text] [Related]

  • 37. Reversal of antifungal resistance mediated by ABC efflux pumps from Candida albicans functionally expressed in yeast.
    Schuetzer-Muehlbauer M, Willinger B, Egner R, Ecker G, Kuchler K.
    Int J Antimicrob Agents; 2003 Sep 10; 22(3):291-300. PubMed ID: 13678837
    [Abstract] [Full Text] [Related]

  • 38. Stable azole drug resistance associated with a substrain of Candida albicans from an HIV-infected patient.
    White TC, Pfaller MA, Rinaldi MG, Smith J, Redding SW.
    Oral Dis; 1997 May 10; 3 Suppl 1():S102-9. PubMed ID: 9456667
    [Abstract] [Full Text] [Related]

  • 39. Reduced azole susceptibility in genotype 3 Candida dubliniensis isolates associated with increased CdCDR1 and CdCDR2 expression.
    Pinjon E, Jackson CJ, Kelly SL, Sanglard D, Moran G, Coleman DC, Sullivan DJ.
    Antimicrob Agents Chemother; 2005 Apr 10; 49(4):1312-8. PubMed ID: 15793103
    [Abstract] [Full Text] [Related]

  • 40. Synthetic Organotellurium Compounds Sensitize Drug-Resistant Candida albicans Clinical Isolates to Fluconazole.
    Reis de Sá LF, Toledo FT, Gonçalves AC, Sousa BA, Dos Santos AA, Brasil PF, Duarte da Silva VA, Tessis AC, Ramos JA, Carvalho MA, Lamping E, Ferreira-Pereira A.
    Antimicrob Agents Chemother; 2017 Jan 10; 61(1):. PubMed ID: 27821447
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 63.